A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure
Recruiting now · Phase 2
Conditions studied: Heart Failure With Preserved Ejection Fraction
In brief
The purpose of this study is to assess the performance of 68Ga- FAPI PET in heart failure with preserved ejection fraction (HFpEF)
Key facts
- Study ID
- NCT07083011
- Run by
- Mayo Clinic
- People needed
- 35
- Starts
- 2025-11-01
- Expected to finish
- 2027-07-01
- Last updated by the study team
- 2026-07-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- Mayo Clinic in Rochester — Rochester, Minnesota, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.